Clinigence Holdings (NUTX) has provided an update.
Scott J. Saunders, a seasoned financial and strategic advisor with extensive experience in healthcare and various other industries, has been appointed as a director of a company following the passing of John Waters. Set to begin his term on April 11, 2024, Saunders brings a wealth of knowledge from his leadership at a boutique investment bank and his involvement in numerous corporate transactions. Recognized for his independence under Nasdaq rules, he will be compensated in line with the company’s standards for non-employee directors and will serve until the 2024 Annual Meeting of Stockholders or until his successor is elected.
For a thorough assessment of NUTX stock, go to TipRanks’ Stock Analysis page.
